Rapid CommunicationImmunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients
Introduction
The presence of antinuclear antibodies (ANA) is a hallmark of SLE and one of its diagnostic criteria established by the American College of Rheumatology [1]. ANA are seen in 90–95% of patients with SLE. It is traditionally detected by indirect immunofluorescence (IF) assay in which the antibodies of the patients' sera that bind to the nucleus of Hep-2 human epipharynx carcinoma cells are detected by fluorescein isothiocyanate-conjugated anti-human IgG, using fluorescence microscopy [1]. The IF technique also provides information on the pattern of fluorescence, such as homogeneous, peripheral, nucleolar, or speckled [1]. Such patterns are relevant for antigen specificity and they have been associated with autoimmune disease subsets [1]. Notwithstanding, the detection of ANA by IF is laborious and requires an experienced technician. Flow cytometry with autoantigen-coated fluorescent beads (FB) has been gaining popularity for several years [2]. FB-based techniques, also commonly referred to as Reflex ANA, are claimed to have multiple advantages, such as simultaneous testing for recognition of several antigens, automation, cost effectiveness, and high sensitivity [2]. This ANA detection technique which was also used in our study, however, has not been systematically validated against IF ANA in patients with SLE and therefore its utility remains unproven. After replacement of the traditional Hep-2 cell-based IF with the FB assay at our Institution, we encountered 11 patients who met the diagnostic criteria for SLE, but tested ANA negative by FB assay. All of these patients were subsequently tested ANA-positive using the IF assay, which was retained by our laboratory for confirmatory testing. This was of concern because the FB technique was being offered as the primary screening method for the diagnosis of SLE. We therefore decided to conduct a retrospective study to analyze how these two methods of ANA detection correlated in SLE and non-SLE patients and compared their sensitivity and specificity for the diagnosis of SLE.
Section snippets
Patients and methods
Based on prior authorization by our Institutional Review Board for the studies of human subjects, we retrospectively analyzed all patients tested for ANA both by IF and FB in the time period of 1/1/03 through 4/30/06. Patients that had an antibody titer of more than 1:50 by IF were considered to have a positive test [1]. The Athena MultiLyte assay employing the Luminex microsphere technology (Zeus Scientific, Raritan, NJ), was used for flow cytometry-based (FB) ANA screening. We then studied
Results
FB-based ANA screening was done on 984 patients at our institution in the period from 1/1/03 to 4/30/06. Sera of 385 of these patients were also tested in parallel for the presence of ANA by IF. The electronic charts of these 385 patients were reviewed. The results of ANA testing are shown in Table 1. The distribution of ANA test results was significantly different (χ2 = 73.12; p < 0.0001) due to a marked discordance of double-negative and double-positive results. The concordance of the FB-negative
Discussion
Antinuclear autoreactivity in patients with SLE was discovered in 1948 with the first detection of the LE (lupus erythematosus) cell [4]. Detection of ANA by indirect IF was introduced in 1957 [5]. In this assay, test sera are incubated with substrate cells, such as Hep-2 cells, at different dilutions and antibody binding is detected by fluorescein isothiocyanate-conjugated IgG by direct visualization under a fluorescent microscope. Because of high sensitivity, it is an excellent screening
References (12)
- et al.
Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy
J. Autoimmun.
(2004) - et al.
Analysis of human sera that are polyreactive in an addressable laser bead immunoassay
Clin. Immunol.
(2006) - et al.
Suppression of non-specific binding in serological Luminex assays
J. Immunol. Methods
(2006) - et al.
Comparison of a multiplex, bead-based fluorescent assay an immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum
J. Immunol. Methods
(2006) - et al.
Range of antinuclear antibodies in “healthy” individuals
Arthritis Rheum.
(1997) - et al.
Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases
Autoimmunity
(2005)